198 related articles for article (PubMed ID: 12553001)
1. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
Horiguchi-Yamada J; Fukumi S; Saito S; Nakayama R; Iwase S; Yamada H
Anticancer Res; 2002; 22(6C):3827-32. PubMed ID: 12553001
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
Mitchell KO; El-Deiry WS
Cell Growth Differ; 1999 Apr; 10(4):223-30. PubMed ID: 10319992
[TBL] [Abstract][Full Text] [Related]
3. Concentration-dependent variable effects of etoposide on the cell cycle of CML cells.
Fukumi S; Horiguchi-Yamada J; Iwase S; Ohno T; Yamada H
Anticancer Res; 2000; 20(5A):3105-10. PubMed ID: 11062729
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
5. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
6. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Ceballos E; Delgado MD; Gutierrez P; Richard C; Müller D; Eilers M; Ehinger M; Gullberg U; León J
Oncogene; 2000 Apr; 19(18):2194-204. PubMed ID: 10822369
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1.
Kolomeichuk SN; Bene A; Upreti M; Dennis RA; Lyle CS; Rajasekaran M; Chambers TC
Mol Pharmacol; 2008 Jan; 73(1):128-36. PubMed ID: 18094076
[TBL] [Abstract][Full Text] [Related]
8. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells.
Dong J; Naito M; Tsuruo T
Oncogene; 1997 Aug; 15(6):639-47. PubMed ID: 9264404
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
Richie JP
J Urol; 2005 Sep; 174(3):931-2. PubMed ID: 16093994
[No Abstract] [Full Text] [Related]
10. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD
In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
[TBL] [Abstract][Full Text] [Related]
12. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1.
Vigneron A; Roninson IB; Gamelin E; Coqueret O
Cancer Res; 2005 Oct; 65(19):8927-35. PubMed ID: 16204065
[TBL] [Abstract][Full Text] [Related]
13. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
[TBL] [Abstract][Full Text] [Related]
14. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment.
Chen S; Gomez SP; McCarley D; Mainwaring MG
Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828
[TBL] [Abstract][Full Text] [Related]
15. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells.
Lu HR; Meng LH; Huang M; Zhu H; Miao ZH; Ding J
Cancer Chemother Pharmacol; 2005 Mar; 55(3):286-94. PubMed ID: 15592835
[TBL] [Abstract][Full Text] [Related]
16. AP4 encodes a c-MYC-inducible repressor of p21.
Jung P; Menssen A; Mayr D; Hermeking H
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15046-51. PubMed ID: 18818310
[TBL] [Abstract][Full Text] [Related]
17. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
18. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation.
Lerga A; Crespo P; Berciano M; Delgado MD; Cañelles M; Calés C; Richard C; Ceballos E; Gutierrez P; Ajenjo N; Gutkind S; León J
Cell Growth Differ; 1999 Sep; 10(9):639-54. PubMed ID: 10511314
[TBL] [Abstract][Full Text] [Related]
19. c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor.
Russo P; Arzani D; Trombino S; Falugi C
J Pharmacol Exp Ther; 2003 Jan; 304(1):37-47. PubMed ID: 12490573
[TBL] [Abstract][Full Text] [Related]
20. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]